August 2013

Transvaginal mesh (TVM) is a mesh implant used to treat damaged vaginal tissues.  One condition TVM has been commonly used to treat is called pelvic organ prolapse (POP).  POP is characterized by weakening of the tissues that hold the pelvic organs in place, and occurs in 30-50% of women.

An observational study, titled “Total

In the United States alone, over 300,000 pelvic floor reconstructions and urinary incontinence are performed.  Around 29 percent of these surgeries are reoperations.  The high failure rate of older methods gave way to the development of vaginal mesh kits in 2005.  Mesh-augmented vaginal prolapse repairs have shown to improve anatomical outcomes and are associated with

In 2004, the FDA cleared the use of synthetic vaginal mesh delivery systems.  The high failure rates from traditional vaginal colporrhaphy and apical suspension procedures using native tissue is what gave way for the development of the new mesh method.  Familiarity for surgeons with the transobturator region increased as a result of the deployment of